X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with GSK Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs GSK PHARMA - Comparison Results

GSK PHARMA 
   Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS GSK PHARMA DR. DATSONS LABS/
GSK PHARMA
 
P/E (TTM) x -10.9 66.9 - View Chart
P/BV x 0.2 11.7 1.4% View Chart
Dividend Yield % 0.0 1.1 -  

Financials

 DR. DATSONS LABS   GSK PHARMA
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
GSK PHARMA
Mar-17
DR. DATSONS LABS/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs1263,838 3.3%   
Low Rs312,637 1.2%   
Sales per share (Unadj.) Rs133.0354.2 37.5%  
Earnings per share (Unadj.) Rs0.239.8 0.4%  
Cash flow per share (Unadj.) Rs6.642.9 15.4%  
Dividends per share (Unadj.) Rs030.00 0.0%  
Dividend yield (eoy) %00.9 0.0%  
Book value per share (Unadj.) Rs128.8236.9 54.4%  
Shares outstanding (eoy) m31.6684.70 37.4%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.69.1 6.4%   
Avg P/E ratio x516.181.4 633.9%  
P/CF ratio (eoy) x11.875.5 15.7%  
Price / Book Value ratio x0.613.7 4.4%  
Dividend payout %075.4 0.0%   
Avg Mkt Cap Rs m2,477274,216 0.9%   
No. of employees `000NA4.7 0.0%   
Total wages/salary Rs m564,830 1.2%   
Avg. sales/employee Rs ThNM6,387.0-  
Avg. wages/employee Rs ThNM1,028.3-  
Avg. net profit/employee Rs ThNM717.1-  
INCOME DATA
Net Sales Rs m4,21130,000 14.0%  
Other income Rs m79728 10.8%   
Total revenues Rs m4,28930,728 14.0%   
Gross profit Rs m5694,190 13.6%  
Depreciation Rs m204263 77.7%   
Interest Rs m4300-   
Profit before tax Rs m134,655 0.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m0457 0.0%   
Tax Rs m61,744 0.3%   
Profit after tax Rs m53,368 0.1%  
Gross profit margin %13.514.0 96.7%  
Effective tax rate %48.037.5 128.2%   
Net profit margin %0.111.2 1.0%  
BALANCE SHEET DATA
Current assets Rs m6,85216,742 40.9%   
Current liabilities Rs m6,7117,202 93.2%   
Net working cap to sales %3.331.8 10.5%  
Current ratio x1.02.3 43.9%  
Inventory Days Days16152 310.5%  
Debtors Days Days31821 1,532.5%  
Net fixed assets Rs m3,6738,635 42.5%   
Share capital Rs m317847 37.4%   
"Free" reserves Rs m3,76119,222 19.6%   
Net worth Rs m4,07820,069 20.3%   
Long term debt Rs m1,67110 16,708.0%   
Total assets Rs m12,63330,038 42.1%  
Interest coverage x1.0NM-  
Debt to equity ratio x0.40 82,233.1%  
Sales to assets ratio x0.31.0 33.4%   
Return on assets %3.411.2 30.7%  
Return on equity %0.116.8 0.7%  
Return on capital %7.725.5 30.1%  
Exports to sales %22.90-   
Imports to sales %14.30-   
Exports (fob) Rs m964NA-   
Imports (cif) Rs m602NA-   
Fx inflow Rs m964528 182.6%   
Fx outflow Rs m6077,193 8.4%   
Net fx Rs m357-6,665 -5.4%   
CASH FLOW
From Operations Rs m1,3452,360 57.0%  
From Investments Rs m-2,2563,008 -75.0%  
From Financial Activity Rs m-1,200-5,108 23.5%  
Net Cashflow Rs m-2,111260 -810.9%  

Share Holding

Indian Promoters % 4.5 0.0 -  
Foreign collaborators % 0.0 50.7 -  
Indian inst/Mut Fund % 0.0 10.2 -  
FIIs % 1.4 23.8 5.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 15.4 611.0%  
Shareholders   20,807 102,036 20.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   ABBOTT INDIA  NATCO PHARMA  DIVIS LABORATORIES  PIRAMAL ENTERPRISES  ALKEM LABORATORIES  

Compare DR. DATSONS LABS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Volatile Day in Red; Pharma Stocks Lose Most(Closing)

After opening the day in green, share markets in India witnessed volatile trading activity throughout the day and ended the day on a negative note.

Related Views on News

GSK PHARMA Announces Quarterly Results (4QFY18); Net Profit Down 6.4%

May 28, 2018 | Updated on May 28, 2018

For the quarter ended March 2018, GSK PHARMA has posted a net profit of Rs 1 bn (down 6.4% YoY). Sales on the other hand came in at Rs 7 bn (down 4.5% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

Hindustan Aeronautics IPO: Yet Another Play on India's Defence Sector (IPO)

Mar 14, 2018

Should you apply for the IPO of state-run military aircraft maker Hindustan Aeronautics?

Bharat Dynamics IPO: Worth Betting on Defence Manufacturing? (IPO)

Mar 12, 2018

Should you apply for the IPO of Bharat Dynamics, India's first state-owned missile manufacturer?

Apollo Micro Systems Ltd. (IPO)

Jan 9, 2018

Should you subscribe to the IPO of Apollo Micro Systems Ltd?

Khadim India Ltd. (IPO)

Oct 31, 2017

Should you subscribe to the IPO of Khadim India Ltd?

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS - SUN PHARMA COMPARISON

COMPARE DR. DATSONS LABS WITH

MARKET STATS